Author: NWN
NORTHWOODS NETS Minnesota Carcinoid and Neuroendocrine Cancer Support info@northwoodsnets.org Contact: Dawn Marie Peterson dawnmarie@northwoodsnets.org 612.314.9997 PRESS RELEASE For Immediate Release November 7, 2016 GOVERNOR MARK DAYTON PROCLAIMS NOVEMBER 10, 2016 AS NET CANCER AWARENESS DAY This NET Cancer Day is…
Join us for our regularly scheduled support group meeting on November 13th and meet Dr. Thor Halfdanarson. This meeting takes place three days after NET Cancer Day and is our last for 2016. Dr. Thor will be giving an overview presentation…
NEWS RELEASE FOR IMMEDIATE RELEASE LEXICON ANNOUNCES PUBLICATION OF TELESTAR STUDY RESULTS FOR TELOTRISTAT ETHYL IN THE JOURNAL OF CLINICAL ONCOLOGY Results from Pivotal Phase 3 Clinical Study of Telotristat Ethyl Show Clinical Benefit in Patients with Carcinoid Syndrome The…
We are pleased to announce that Governor Dayton has proclaimed Thursday, November 10, 2016 as NET Cancer Day in the state of Minnesota. This is the fifth year that he has offered his support in raising awareness for rare neuroendocrine…
Dr. Liu, one of our esteemed NET specialists in the U.S. has a Facebook page where he offers a Question and Answer session once a month. This month, he featured guest Nancy Teixeira, a registered RN who works with Wren…
by John McDougall, MD Steve Jobs gave tacit permission and encouragement for me to write this newsletter article about the medical and nutritional aspects of his life when he commissioned his biographer to tell a true account. “I wanted my…
An investigative report from KARE-11 explains how even if you do your research picking an insurance policy, your doctors, clinics and other medical team members may not be in your network or can drop out of the network without your…
The National NET Patient conference will be held Sept 22- 24th in New Orleans. There will be over 20 of the top specialist from around the country flying in to speak at the event. This is a 2-1/2 day event. Come join…
We are excited to participate in the Carcinoid Syndrome Impact Survey, which is designed to help better understand the impact that carcinoid syndrome has on patient lives, while also exploring physicians’ approaches to treating the disease. This survey is groundbreaking in that…
NEW ORLEANS – Ochsner Medical Center – Kenner and the New Orleans Neuroendocrine Tumor Specialists (NOLANETS) have launched the Gallium 68 Scan Study to test the effectiveness of this diagnostic tool to detect neuroendocrine tumors. Ochsner – Kenner is the…
